PSNL: Personalis, Inc.
Performance
PSNL +130.16%
Watchlist
Select an item
Summary
PSNL at a glance
PSNL returned +130.16% over the past year and -4.95% a year over five years. Its worst drop in that year was -55.20%, smaller than 17% of stocks on Redstone, and its Sharpe ratio of 1.37 beats 88% of stocks on Redstone. It pays no dividends.
Current Drawdown
-13.22%
Rolling Volatility
13.22%
Actions
Metrics
Risk Indicators
Alpha90.15%
Beta2.41x
Sharpe1.37
Sortino2.23
Omega1.29
Calmar2.36
Martin4.74
Profile
About PSNL
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services.
- Sector
- Health Care
- Industry
- Services: Medical Laboratories
- Market cap
- $1.7B
- Listed
- Jun 2019
- Employees
- 260
- Headquarters
- Fremont, CA
- Website
- personalis.com
Comparisons